药物开发 药物开发
1Denali Therapeutics, South San Francisco, CA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
一种针对转移素受体 (TfR) 的新型抗体运输载体 (ATV) 减少了ARIA类病变,并通过增强大脑传递来改善粉样β (Aβ) 免疫疗法的疗效.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 免疫疗法面临安全挑战,因为粉样蛋白相关的成像异常 (ARIA).
- 目前的治疗方法在有效的脑部输送和管理ARIA副作用方面扎.
研究的目的:
- 开发一种抗体运输车辆 (ATV),以改善粉样β (Aβ) 抗体的向大脑输送.
- 在小鼠模型中,以减少ARIA类病变并增强Aβ斑块参与.
主要方法:
- 设计了一种针对转移素受体 (TfR) 的抗体运输车辆 (ATV).
- 引入了不对称的Fc突变 (ATVcisLALA),以调节效应器功能并减轻TfR负债.
- 携带Aβ抗体的ATV (ATVcisLALA:Aβ) 在粉样沉积的小鼠模型中进行了测试.
主要成果:
- ATVcisLALA:Aβ表现出广泛的大脑辅酶分布,与传统的抗AβIgG不同.
- ATVcisLALA:Aβ显著减少了类似ARIA的病变和血管炎症.
- 设计的ATV改善了Aβ斑块的向接触,同时减轻了血液学副作用.
结论:
- 亚特维西斯拉拉可以增强Aβ抗体在血脑屏障中的生物分布.
- 这种方法有可能提高阿尔茨海默病的Aβ免疫治疗的安全性和有效性.
- 用工程抗体准TfR为AD治疗提供了一个有希望的策略.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
